GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » 5-Year Yield-on-Cost %

PHVS (Pharvaris NV) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 16, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV 5-Year Yield-on-Cost %?

Pharvaris NV's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Pharvaris NV's 5-Year Yield-on-Cost % or its related term are showing as below:



PHVS's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.65
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Pharvaris NV's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Pharvaris NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharvaris NV's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharvaris NV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Pharvaris NV's 5-Year Yield-on-Cost % falls into.


;
;

Pharvaris NV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Pharvaris NV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Pharvaris NV  (NAS:PHVS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Pharvaris NV 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharvaris NV Business Description

Traded in Other Exchanges
Address
Emmy Noetherweg 2, Leiden, NLD, 2333 BK
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.